The acquisition of the Chemistry, Manufacturing and Controls team adds more than 35 specialists in biologics development, production oversight, and regulatory strategy.
The agreement establishes dedicated manufacturing capacity and supply chain controls for consumables used in Ori’s automated cell therapy manufacturing platform.
A Swedish government agency awarded Mendus about $100,000 to establish a donor-derived cell manufacturing platform using a technology that stimulates NK cell expansion.
The new Lipid Innovation Center will manufacture pharmaceutical lipids for RNA medicines and other advanced therapies, with full production capacity expected by mid-2027.
The expanded authorization allows the German CDMO to manufacture sterile viral drug substances and investigational medicinal products, including advanced therapies.
The €5 million project adds fermentation capabilities and downstream processing equipment, increasing production capacity at the León site to 58,000 liters.